Is Wolff Parkinson White life-threatening?

Is Wolff Parkinson White life-threatening?

With treatment, the condition can normally be completely cured. WPW syndrome can sometimes be life-threatening, particularly if it occurs alongside a type of irregular heartbeat called atrial fibrillation. But this is rare and treatment can eliminate this risk.

What are the chances of dying from WPW?

Only a small percentage of patients with WPW syndrome (<1%) are at risk for sudden cardiac death (SCD). In patients who present with preexcited AF, cardiac electrophysiologic studies and radiofrequency (RF) catheter ablation may be curative.

How is SVT treated during pregnancy?

Adenosine is the agent most commonly used during pregnancy, with conversion to normal sinus rhythm in over 80% of cases of acute SVT if non-pharmacological manoeuvres have failed, although manoeuvres such as carotid sinus massage and Valsalva maneuver to control SVT are well tolerated during pregnancy.

How does WPW cause sudden death?

The most common arrhythmia in WPW patients is atrioventricular re-entrant tachycardia, which occurs in 80% of cases. Atrial fibrillation is common, occurring in one-third of patients and is a potentially life-threatening arrhythmia. Ventricular fibrillation is the most common cause of sudden death in WPW patients.

Which beta blocker is safe in pregnancy?

There is a general consensus that labetalol is safer than other β-blockers during pregnancy, and this drug is rapidly becoming the first-line choice in conditions, such as chronic hypertension during pregnancy.

Does SVT make pregnancy high risk?

Pregnancy may predispose to and exacerbate symptoms of paroxysmal SVT. Several case reports8 and a retrospective study of 60 patients with documented SVT3 showed pregnancy to be associated with both an increased risk, and an exacerbation of symptoms.

Is beta blocker OK when pregnant?

β-Blockers are the most commonly used class of medication for treating cardiac conditions in pregnant women. Despite the common use of this class of medication, data that support its safety are limited. β-Blockers cross the placenta and potentially can cause physiological changes in the fetus.